M366 White Pill: Hydrocodone 7.5/325 Identification and Risks

The M366 white pill contains 7.5 mg of hydrocodone bitartrate and 325 mg of acetaminophen. Current DailyMed labeling describes M366 as a white, oval, unscored prescription tablet. Hydrocodone is an opioid, so the medication is a Schedule II controlled substance.

M366 sits between two closely related Mallinckrodt/SpecGx hydrocodone tablets that readers often confuse with it: M365 contains 5 mg/325 mg, while M367 contains 10 mg/325 mg. The three pills share acetaminophen strength but differ in hydrocodone strength and physical markings. That makes the imprint important when checking a pharmacy-dispensed medication.

A pill that looks like M366 is not automatically authentic. Counterfeit tablets can copy legitimate imprints. If a pill did not come from a licensed pharmacy in a properly labeled prescription container, its color and imprint alone cannot establish what is inside it.

M366 Pill Identification

What Is the M366 White Pill?

M366 is an immediate-release combination pain medication. It contains hydrocodone, an opioid analgesic, and acetaminophen, a non-opioid pain reliever. Current labeling describes hydrocodone/acetaminophen tablets as treatment for pain severe enough to require an opioid when alternative treatments are inadequate.

The imprint is not a drug name. “M366” identifies a particular manufactured tablet. The clinically important ingredients are hydrocodone 7.5 mg and acetaminophen 325 mg.

M365 vs. M366 vs. M367

This comparison is useful because a reader may recognize the “M36” portion of an imprint but misread the final digit. The difference between 5 mg, 7.5 mg, and 10 mg of hydrocodone is medically meaningful. A pill should be identified from its complete imprint rather than from color or general shape.

How Strong Is M366?

Each M366 tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. The 7.5 mg value is the labeled tablet strength, not a universal dose recommendation.

Hydrocodone is a full opioid agonist. Current labeling warns that respiratory and central nervous system depression can limit safe use. A person with little opioid tolerance, breathing problems, older age, or exposure to other sedating substances may be more vulnerable to serious effects.

What Is M366 Prescribed For?

Hydrocodone/acetaminophen tablets are used for pain severe enough to require an opioid when alternative treatments are inadequate. They should be used only by the patient for whom they were prescribed.

Prescription opioids should never be shared. The dose and formulation selected for one patient may be unsafe for another person because opioid tolerance, other medicines, liver function, respiratory disease, pregnancy, and other factors can change the risk.

What Does Hydrocodone Do?

Hydrocodone acts primarily at mu-opioid receptors. Its desired effect is analgesia, but the same opioid activity can produce sedation, mental clouding, constipation, nausea, and respiratory depression. With repeated exposure, tolerance and physical dependence can develop.

Hydrocodone can also cause opioid use disorder. Schedule II status reflects both accepted medical use and a high potential for misuse and dependence.

Why Does M366 Contain Acetaminophen?

Acetaminophen adds non-opioid pain relief, but it also creates a separate liver-safety concern. FDA advises adults and children age 12 and older not to exceed 4,000 mg of acetaminophen in 24 hours from all medicines combined unless a clinician has given more restrictive instructions.

People can accidentally double up because acetaminophen appears in many cold, flu, headache, and pain products. The total from every medication matters.

How Long Does Hydrocodone Take to Work?

Current DailyMed pharmacokinetic information for hydrocodone/acetaminophen reports that, after a 10 mg oral hydrocodone dose in a small study, maximum serum levels occurred at about 1.3 hours and the measured hydrocodone half-life was about 3.8 hours.

Peak blood concentration is not identical to the moment a patient first feels relief, and half-life is not the same as duration of noticeable effects or a drug-testing window. Food, metabolism, other medications, and health conditions can affect exposure.

Common Side Effects of M366

Current labeling reports common hydrocodone/acetaminophen effects such as:

• Lightheadedness
• Dizziness
• Sleepiness or sedation
• Nausea
• Vomiting
• Constipation
• Tiredness
• Headache

Because opioid effects can impair judgment and coordination, patients should follow the prescription label about driving or operating machinery.

M366 and Alcohol

Alcohol can intensify hydrocodone’s central nervous system depressant effects. Current labeling warns that hydrocodone used with alcohol or other CNS depressants can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.

Alcohol also matters because M366 contains acetaminophen. Liver health and drinking patterns can affect the clinician’s assessment of acetaminophen risk.

M366 and Benzodiazepines

Combining hydrocodone with benzodiazepines such as alprazolam, clonazepam, lorazepam, or diazepam can substantially increase sedation and respiratory-depression risk. Current opioid labeling advises reserving such combinations for situations where alternatives are inadequate and monitoring closely.

Can You Overdose on M366?

Yes. Hydrocodone can cause life-threatening respiratory depression, and excessive acetaminophen can cause severe liver injury.

Possible opioid overdose signs include inability to wake, very slow or stopped breathing, choking or gurgling sounds, severe discoloration of the lips or nails, and pinpoint pupils. Call emergency services and give naloxone if it is available when opioid overdose is suspected.

Can M366 Cause Addiction?

Yes. Hydrocodone can cause opioid use disorder. Warning signs can include taking more than intended, repeated unsuccessful attempts to cut down, craving, obtaining pills from nonmedical sources, or continuing use despite health, work, family, or legal harm.

Physical dependence is different from addiction. A person can become physically dependent while taking an opioid as prescribed. Dependence means abrupt discontinuation may trigger withdrawal.

M366 Withdrawal

Hydrocodone withdrawal can include restlessness, watery eyes, runny nose, yawning, sweating, chills, muscle aches, anxiety, abdominal cramps, insomnia, nausea, vomiting, diarrhea, and increased heart rate or blood pressure.

Current labeling specifically warns against abruptly stopping hydrocodone in a person who may be physically dependent. A taper should be individualized rather than copied from a generic schedule.

Can an M366 Pill Be Counterfeit?

Yes. FDA warns that counterfeit medicines can contain the wrong ingredient, too much or too little active ingredient, no active ingredient, or other harmful substances. A copied imprint does not make a pill authentic.

If a tablet came from a licensed pharmacy but looks different from a prior refill, contact the pharmacist. Generic suppliers can change. If the pill came from an unlicensed or unknown source, do not rely on appearance alone.

What Should You Do With an Unknown M366 Pill?

Do not take a loose tablet based only on an online image match. Check the prescription container, contact the dispensing pharmacy when appropriate, keep controlled medications secured, and use an authorized medication take-back option for unwanted pills.

Treatment for Hydrocodone Misuse

A person who is repeatedly taking more hydrocodone than prescribed, buying pills outside medical care, experiencing withdrawal, or struggling to control use can be evaluated for opioid use disorder. Evidence-based treatment can include medications such as buprenorphine, methadone, or naltrexone along with medical and behavioral care.

Rehabs.Today can also be used to compare detox centers and residential treatment programs.

M366 vs. T257

M366 and T257 both contain hydrocodone and acetaminophen, but the labeled strengths differ. M366 contains hydrocodone 7.5 mg with acetaminophen 325 mg. T257 contains hydrocodone 5 mg with acetaminophen 325 mg. They also use different imprints and tablet designs.

This comparison matters because people often search by a partial description such as “white hydrocodone pill.” That description is not specific enough. Hydrocodone/acetaminophen tablets exist in several strengths and under several imprints. The complete imprint is the most useful visual clue when checking a pharmacy-dispensed tablet.

How Long Does Hydrocodone From M366 Stay in Your System?

There is no single detection window that applies to every person or every drug test. The noticeable pain-relieving or sedating effects end sooner than all traces of the drug and its metabolites disappear from the body.

SAMHSA guidance has listed a typical urine detection window of about two days for hydrocodone and its metabolite hydromorphone, while also noting that detection depends on the assay and cutoff. Some standard opiate screens may not reliably detect hydrocodone unless it is specifically included.

Test type, amount used, frequency of use, time since the last dose, metabolism, kidney and liver function, and laboratory cutoff can all change a result. A person should not use a generic detection estimate to decide when it is safe to drive, mix medications, or resume another sedating drug.

Who Has a Higher Risk of Serious M366 Side Effects?

Opioid risk is not identical for every patient. Current hydrocodone labeling gives particular attention to respiratory depression, especially during treatment initiation and after dose changes. Risk can also be more concerning in people with significant breathing problems, older or frail patients, and people taking other sedating medicines.

Liver disease and other sources of acetaminophen matter separately because M366 contains 325 mg of acetaminophen. A clinician or pharmacist should know about every prescription and over-the-counter medicine a patient uses so duplicate acetaminophen exposure and sedating combinations can be recognized.

M366 During Pregnancy and Breastfeeding

Current opioid labeling warns that prolonged opioid use during pregnancy can cause neonatal opioid withdrawal syndrome. A newborn exposed to opioids during pregnancy may require prompt recognition and treatment after delivery.

Hydrocodone can also pass into breast milk. A breastfeeding patient taking an opioid should follow the prescriber’s advice and seek medical attention if an infant develops unusual sleepiness, poor feeding, limpness, or breathing difficulty.

How Should M366 Be Stored and Disposed Of?

Controlled opioids should be stored securely, out of sight and reach of children and away from people who might take them without a prescription. A single accidental opioid ingestion can be dangerous for a child or a person without opioid tolerance.

Unused prescription opioids should be removed from the home through an authorized drug take-back program when possible. Patients can also follow current FDA disposal instructions when a take-back option is not readily available.

When Is an M366 Reaction an Emergency?

Call emergency services for very slow or stopped breathing, inability to wake the person, severe confusion or loss of consciousness, suspected overdose, severe allergic swelling, or a suspected dangerous acetaminophen ingestion. If opioid overdose is possible, give naloxone when available while emergency help is being obtained.

Frequently Asked Questions About M366

What pill is M366?

M366 is hydrocodone bitartrate 7.5 mg / acetaminophen 325 mg in current DailyMed labeling.

Is M366 stronger than M365?

The labeled M366 tablet contains 7.5 mg hydrocodone while M365 contains 5 mg. Both contain 325 mg acetaminophen in the current product line.

Is M366 weaker than M367?

By labeled hydrocodone strength, yes. M367 contains 10 mg hydrocodone and 325 mg acetaminophen.

Is M366 Schedule II?

Yes. Hydrocodone combination products are Schedule II controlled substances under current federal scheduling.

Is M366 scored?

Current DailyMed labeling describes M366 as an unscored oval white tablet.

Can a fake pill say M366?

Yes. Counterfeit manufacturers can reproduce legitimate imprints. Source and pharmacy chain of custody matter.

Sources

• DailyMed: Hydrocodone Bitartrate and Acetaminophen Tablets — current labeling, strengths, appearance, warnings, pharmacokinetics and Schedule II status.
• Drug Enforcement Administration: Drug Scheduling — current federal Schedule II classification for hydrocodone combination products and oxycodone.
• U.S. Food and Drug Administration: Acetaminophen — total daily acetaminophen safety information.
• U.S. Food and Drug Administration: Counterfeit Medicine — counterfeit prescription-drug risks.
• Centers for Disease Control and Prevention: Overdose Prevention — opioid overdose recognition and naloxone information.
• SAMHSA: Substance Use Treatment Options — evidence-based opioid use disorder treatment options.